{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:26:30Z","timestamp":1771302390684,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofhospitalinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Infection"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jhin.2025.07.029","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:15:21Z","timestamp":1755616521000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Variability in follow-up strategies for carbapenemase-producing Gram-negative carriers: results from an international scoping survey"],"prefix":"10.1016","volume":"165","author":[{"given":"A.C.","family":"B\u00fcchler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.F.","family":"Voor in \u2019t holt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Severin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0496-7038","authenticated-orcid":false,"given":"M.C.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhin.2025.07.029_bib1","series-title":"Antimicrobial resistance in the EU\/EAA (EARS-Net) \u2013 Annual epidemiological report 2022","year":"2023"},{"issue":"31","key":"10.1016\/j.jhin.2025.07.029_bib2","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.30.1700775","article-title":"Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016","volume":"23","author":"Galani","year":"2018","journal-title":"Eurosurveillance"},{"issue":"9","key":"10.1016\/j.jhin.2025.07.029_bib3","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.9.1900123","article-title":"Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018","volume":"24","author":"Brolund","year":"2019","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jhin.2025.07.029_bib4","series-title":"Rapid risk assessment: carbapenem-resistant Enterobacterales \u2013 third update","year":"2025"},{"key":"10.1016\/j.jhin.2025.07.029_bib5","series-title":"Carbapen-em-resistant Enterobacteriaceae, second update \u2013 26 September 2019","year":"2019"},{"key":"10.1016\/j.jhin.2025.07.029_bib6","series-title":"The healthcare infection control practices advisory committee 2007 guideline for isolation precautions: prevention transmission of infectious agents in healthcare settings","author":"Siegel","year":"2007"},{"key":"10.1016\/j.jhin.2025.07.029_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13756-017-0259-z","article-title":"Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control","volume":"6","author":"Magiorakos","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jhin.2025.07.029_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cmi.2018.10.007","article-title":"Experiences of carriers of multidrug-resistant organisms: a systematic review","volume":"25","author":"Rump","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2025.07.029_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/ice.2017.258","article-title":"Direct costs of a contact isolation day: a prospective cost analysis at a Swiss university hospital","volume":"39","author":"Roth","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2025.07.029_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jhin.2020.12.013","article-title":"The daily direct costs of isolating patients identified with highly resistant micro-organisms in a non-outbreak setting","volume":"103","author":"van Dijk","year":"2021","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2025.07.029_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/ice.2017.245","article-title":"Duration of contact precautions for acute-care settings","volume":"39","author":"Banach","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2025.07.029_bib12","series-title":"Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities","year":"2017"},{"key":"10.1016\/j.jhin.2025.07.029_bib13","series-title":"Data from the ECDC surveillance atlas \u2013 antimicrobial resistance: European Center for Disease Prevention and Control (ECDC)","year":"2022"},{"key":"10.1016\/j.jhin.2025.07.029_bib14","unstructured":"World Health Organization Regional Office for Europe\/European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2022 \u2013 2020 data."},{"key":"10.1016\/j.jhin.2025.07.029_bib15","series-title":"English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) report 2022 to 2023","year":"2023"},{"key":"10.1016\/j.jhin.2025.07.029_bib16","unstructured":"Swiss Centre for Antibiotic Resistance (ANRESIS). Resistance Data Human Medicine [29 December 2024]. Available at: https:\/\/www.anresis.ch\/antibiotic-resistance\/resistance-data-human-medicine\/ [last accessed September 2025]."},{"issue":"Suppl I","key":"10.1016\/j.jhin.2025.07.029_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12427","article-title":"ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients","volume":"20","author":"Tacconelli","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2025.07.029_bib18","series-title":"Should individuals who are colonized or infected with CPO be rescreened to assess clearance?","year":"2024"},{"key":"10.1016\/j.jhin.2025.07.029_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciaa123","article-title":"National policy for carbapenem-resistant Entero-bacteriaceae (CRE) clearance and discontinuation of contact precautions for CRE carriers in post-acute care hospitals in Israel: impact on isolation-days and new acquisitions","volume":"72","author":"Ben-David","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhin.2025.07.029_bib20","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.ajic.2021.06.006","article-title":"Duration of carbapenemase-producing Enterobacteriales carriage among ICU patients in Miami, FL: a retrospective cohort study","volume":"49","author":"Jimenez","year":"2021","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jhin.2025.07.029_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jhin.2023.01.022","article-title":"Time to intestinal clearance of carbapenemase-producing Enterobacterales in hospital patients: a longitudinal retrospective observational cohort study","volume":"135","author":"Henoun","year":"2023","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhin.2025.07.029_bib22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1017\/ice.2015.169","article-title":"Clearance rate of carbapenemase-producing Enterobacteriaceae carriage among hospitalized patients","volume":"36","author":"Kim","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jhin.2025.07.029_bib23","doi-asserted-by":"crossref","first-page":"E190","DOI":"10.1111\/1469-0691.12099","article-title":"Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage","volume":"19","author":"Feldman","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhin.2025.07.029_bib24","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/jac\/dkw221","article-title":"Natural history and decolonization strategies for ESBL\/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis","volume":"71","author":"Bar-Yoseph","year":"2016","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Hospital Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670125002488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195670125002488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:35:20Z","timestamp":1762292120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195670125002488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":24,"alternative-id":["S0195670125002488"],"URL":"https:\/\/doi.org\/10.1016\/j.jhin.2025.07.029","relation":{},"ISSN":["0195-6701"],"issn-type":[{"value":"0195-6701","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variability in follow-up strategies for carbapenemase-producing Gram-negative carriers: results from an international scoping survey","name":"articletitle","label":"Article Title"},{"value":"Journal of Hospital Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhin.2025.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.","name":"copyright","label":"Copyright"}]}}